Equity Compensation (Tables)
|
6 Months Ended |
Oct. 31, 2025 |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Warrant Activity |
Strategic Advisor warrants and Asset Manager
warrants are accounted for as equity classified share-based compensation award in accordance with ASC 718. Following is a summary of
the activities of warrants for the six months ended October 31, 2025:
Schedule of Warrant Activity
| | |
Number of Warrants | | |
Weighted Average Exercise Price | | |
Aggregate Intrinsic Value | |
| Outstanding as of July 30, 2025 | |
| - | | |
$ | - | | |
| - | |
| Granted | |
| 6,930,697 | | |
| 1.46 | | |
| | |
| Exercised | |
| 2,376,236 | | |
| - | | |
| | |
| Forfeited | |
| - | | |
| | | |
| | |
| Expired | |
| - | | |
| | | |
| | |
| Outstanding as of October 30, 2025 | |
| 4,554,461 | | |
$ | 2.22 | | |
$ | 26,447,530 | |
| Exercisable as of October 30, 2025 | |
| 4,554,461 | | |
$ | 2.22 | | |
$ | 26,447,530 | |
|
| Schedule of Key Assumption Inputs |
The
table below summarizes the key assumption inputs used for the valuation for the six months ended October 31, 2025:
Schedule of Key Assumption Inputs
| | |
Asset Manager Warrants | |
| Stock Price | |
$ | 17.7 | |
| Exercise Price | |
$ | 10.23 | |
| Expected Term (in years) | |
| 5.00 | |
| Risk-free interest rate | |
| 3.77 | % |
| Expected volatility | |
| 110 | % |
| Expected dividend yield | |
| - | |
|
| Schedule of Non Qualified Stock Option |
A
summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended October
31, 2025, are presented in the tables below:
Schedule
of Non Qualified Stock Option
| | |
Number of Options | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual Term | | |
Aggregate Intrinsic Value | |
| | |
| | |
| | |
| | |
| |
| Outstanding, June 7, 2025 | |
| 4,760 | | |
$ | 113.34 | | |
| 3.5 | | |
| - | |
| Granted | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Forfeited | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Expired | |
| (1,111 | ) | |
$ | 52.20 | | |
| - | | |
| - | |
| Outstanding, October 31, 2025 | |
| 3,649 | | |
$ | 131.95 | | |
| 3.5 | | |
| - | |
| Exercisable, October 31, 2025 | |
| 3,649 | | |
$ | 131.95 | | |
| 4.2 | | |
| - | |
|
| Schedule of Restricted Units Activity |
Schedule of Restricted Units Activity
| | |
Number of Units | | |
Weighted Average Grant-Date Fair Value | | |
Aggregate Intrinsic Value | |
| | |
| | |
| | |
| |
| Outstanding, June 7, 2025 | |
| 1,529 | | |
$ | 8.18 | | |
$ | 11,345 | |
| Granted | |
| 530,139 | | |
$ | 8.88 | | |
| 3,934,967 | |
| Vested and settled with share issuance | |
| (4,189 | ) | |
$ | 8.95 | | |
| (31,082 | ) |
| Forfeited/cancelled | |
| - | | |
$ | - | | |
| - | |
| Outstanding, October 31, 2025 | |
| 527,659 | | |
$ | 8.89 | | |
$ | 3,915,230 | |
|
| 2017 Equity Plan and 2021 Equity Plan [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Stock Option Activity |
A
summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity
Plans during the period from June 7, 2025 through October 31, 2025, are presented in the tables below, including information on nonvested
options:
Schedule of Stock Option Activity
| | |
Number of Options | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual Term | | |
Aggregate Intrinsic Value | |
| | |
| | | |
| | | |
| | | |
| | |
| Outstanding as of June 7, 2025 | |
| 18,296 | | |
$ | 83.19 | | |
| 5.20 | | |
| - | |
| Granted | |
| 2,700 | | |
$ | 7.74 | | |
| 9.62 | | |
| - | |
| Exercised | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Forfeited | |
| (450 | ) | |
$ | 7.74 | | |
| - | | |
| - | |
| Expired | |
| (150 | ) | |
$ | 8.99 | | |
| - | | |
| - | |
| Outstanding as of October 31, 2025 | |
| 20,396 | | |
$ | 74.68 | | |
| 5.34 | | |
| - | |
| Exercisable as of October 31, 2025 | |
| 18,146 | | |
$ | 82.98 | | |
| 4.81 | | |
| - | |
|